CNTNAP4 and Parkinson disease: Functionally, in vivo and in vitro experiments demonstrate that high methylation levels can overexpress EBF3, promote CNTNAP4 transcription expression, ameliorate PD behavioral deficits, and inhibit dopamine neuron apoptosis.